Please login to the form below

Not currently logged in
Email:
Password:

Novartis cancer pill makes it onto UK early access list

Novartis buildingJoins Merck’s melanoma drug Keytruda for the MHRA’s accelerated review programme

Just:: Health Communications launches Just//works

Will offer problem solving and multi-discipline advice

Novartis steps up its efforts in immuno-oncology

Novartis buildingDedicated R&D unit created alongside $750m collaboration with Aduro

Open health data network launches in US

'Open Humans’ wants people to share health information to accelerate medical breakthroughs

US sets five-year target to tackle antibiotic resistance

US flagObama to seek $1.2bn in funding to tackle the issue

UK to pay for GSK’s MenB vaccine after year’s delay

GSK - logo on buildingBritish firm says the deal offers ‘fair value’ to the NHS

Eisai’s thyroid cancer drug Lenvima nears EU approval

EISAIPositive recommendation by the CHMP could see the orphan drug used in Europe within three months

Shire links with US hospital for rare disease research

Shire BasingstokeWill work with Cincinnati Children's Hospital Medical Centre novel therapies

The end of hepatitis C?

Next-gen hep C therapies may see the disease's global elimination - but treament access must be stepped up dramatically

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Networks in Health

Networks in Health is the unique global alliance of trusted online physician networks founded and operated by Doctors.net.uk....

Latest intelligence

Capturing "in-the-moment" patient and physician insights
Utilising the benefits of mobile technology...
Webinar: Observational Research
Presenting a window on the world of your customer...
Webinar: The Brazil Conundrum
Conducting research in one of the world's largest pharma markets...